Scott M. Bradfield, MD
Hematology/OncologyResearch Activities
I am the Principal Investigator nationally for a study examining the prevention of neurotoxicity in oncology patients treated with vincristine. The 6-year study will close soon, and the pending results will be very important in helping doctors improve cancer care for children.
Medical Interests
- Minimal residual disease
- Palliative care
- Research into solid tumors
- Safety and quality improvement
- Sarcoma research
- Symptom management and comfort
- Teaching general oncology
-
A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors; Child's Nervous System; (2022).
-
Modern Therapy for Spinal and Paraspinal Ewing Sarcoma: An Update of the University of Florida Experience.; International journal of radiation oncology, biology, physics; (2022).
-
Modern Therapy for Chest Wall Ewing Sarcoma: An Update of the University of Florida Experience.; International journal of radiation oncology, biology, physics; (2022).
-
SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; (2021).
-
Proton radiotherapy for infant rhabdomyosarcoma: Rethinking young age as an adverse prognostic factor.; Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology; (2021).
-
Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.; International journal of radiation oncology, biology, physics; (2020).
-
Treatment Outcomes After Proton Therapy for Ewing Sarcoma of the Pelvis.; International journal of radiation oncology, biology, physics; (2020).
-
Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variation.; Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc; (2020).
-
Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base.; Pediatric blood & cancer; (2019).
-
45 GyRBE for group III orbital embryonal rhabdomyosarcoma.; Acta oncologica (Stockholm, Sweden); (2019).
-
Intravenous and Oral Posaconazole Pharmacokinetics in a Five-Year-Old With Mucor: A Case Report and Review of the Literature.; The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG; (2019).
-
Esophagitis associated with multimodality management of pediatric Ewing sarcoma of thorax.; Pediatric blood & cancer; (2018).
-
False Lung Metastasis: Concurrent Ewing Sarcoma and Minimally Invasive Adenocarcinoma.; Journal of pediatric hematology/oncology; (2018).
-
Eliciting parental values and preferences in the medical decision-making process.; The American journal of bioethics : AJOB; (2015).
-
Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer.; Pediatric blood & cancer; (2014).
-
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults.; Antimicrobial agents and chemotherapy; (2011).
-
When is state intervention justified? An ethics consult gone bad.; Pediatric blood & cancer; (2010).
-
"STOP"-ping harm: when is state intervention justified?; Pediatric blood & cancer; (2010).
-
Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.; Pediatric blood & cancer; (2006).
-
Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.; Cancer; (2004).
-
Graft-versus-leukemia effect in acute lymphoblastic leukemia: the importance of tumor burden and early detection.; Leukemia; (2004).
-
Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases.; Journal of pediatric hematology/oncology; (2003).
- English